Research and Markets (http://www.researchandmarkets.com/reports/c91850) has announced the addition of “Concepts in Genetic Medicine” to their offering.

Concepts in Genetic Medicine offer a coherent collection of uniformly organized short reviews in the field of therapeutic genetic medicine. Each chapter focuses on a current topic (“concept”) to elucidate issues in development of genetic treatments for discuses, presenting critical challenges, strategies for addressing them, and future directions.

Key Topics:
 
– The Evolution of Human Gene Therapy. A Journey from Excessive Hype to Excessive Diffidence to Realty
– Murine Leukemia Virus Based Vectors
– Lentivirus Vectors
– Adenoviral Vectors: History and Perspective
– Adeno-associated Virus Vectors
– The Glass is Half Full: the Goal of Long-term delivery may be Approachable Using SV40-derived Vectors
– Herpes Simplex Virus Vectors
– Nonviral Gene Delivery Systems
– Therapeutic Gene Transfer to Skeletal Muscle
– Gene Therapy for Cardiovascular Disease
– Intra-articular Vector Delivery for Inflammatory Disease
– The Respiratory System as a Platform for Gene Delivery
– The Brain as a Target for Gene Therapy
– Immune Responses to Viral vectors Injected Systemically or into the CNS
– Cancer vaccines
– Genetically Modified T cells for Human Gene Therapy
– Lentiviral Vector Delivery of RNAi Triggers for the Treatment of HIV-1 Infection
– The Manufacture of Genetic Viral Vector Products
– The Manufacture of Adeno-associated Viral Vectors
– Lentivirus Vector Manufacturing
– Safety and Regulatory.
– Assays for the Release of Viral Vector Gene Therapy Products for Clinical Trials
– Safety of Retroviral Vectors: Regulatory and Technical Considerations
– Assays for the Quality Control of Lentiviral Vectors
– Assays for Non-viral vectors
– Assays for the Release of Cellular Gene Therapy Products
– Toxicology for Gene Therapy Products: Concepts and Challenges
– Regulatory Aspects of Gene Therapy Medicinal Products in the European Union
– Venture Capital and Biotechnology Startups
– The role of Investment Banking in the Growth of Biotechnology Companies
– Managing Reimbursment for Gene Therapy Products

For more information visit http://www.researchandmarkets.com/reports/c91850.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
Fax: +353 1 4100 980

Comments

comments